Regardless of whether they know it, many case managers are faced with patients and clients each day who are struggling with opioid use disorder (OUD). As rates of OUD continue to increase, it is essential for case managers to hone their skills of confidently recognizing and addressing the disorder.
Stigma is a major barrier to women with substance use disorder receiving reproductive healthcare and contraceptives. Clinicians should ask women, including those with substance use disorder, about their goals, values, and what they find most important in contraception.
Low libido is the most common sexual complaint, affecting up to 38.7% of women, with up to 12.3% also reporting significant distress associated with this condition. Debate continues about how female desire disorders are characterized, diagnosed, and treated.
Simply reducing the number of opioid prescriptions is not enough, the report authors wrote. Hospitals must be much more proactive in identifying patients with opioid use disorder and initiating treatment wherever those patients are encountered within the treatment process.
Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS) is a proposed disorder first named in 1998 that has been the subject of controversy in the literature. Although the debate has waned somewhat in the United States, it remains a topic of discussion in many European medical journals. A recent systematic review found no evidence for antimicrobial or immunomodulatory treatment for this condition.